Japan Bold Biotechnology Co., Ltd (known as BBT) is a comprehensive health industry group with its own excellent life health technology. BBT committed to develop the world’s most advanced and leading technology including cancer prevention, treatment of immune cells (BAK, NK, DC immunotherapy), exosome research and development, stem cell culture medium for serum-free immune cells, ultra-early stage cancer detection, fermented horse milk exosomes research and manufacturing, high concentration Vitamin C production and over 10 leading biotechnologies.
At the same time, with our top biotechnologies and excellent business operation, BBTF convert the most advanced medical-use biotechnologies development to end-user product at the fastest speed. BBTF act as a pioneer in the field by developing life health technology with most advanced biotechnology.
BBT group run business in different fields independently by Kyosei Medical Symbiology Institute Corporation, Medical Future Co., LTD., and New Business Co., Ltd. Later, BAK Therapy (cancer therapy) immune cell Culture Center (CPC) and Cell Science were also established.
To save patients from the brink of life, and prevent it before happens.
This mission promotes us to become a global advocate leader. While AI starts to shock the world, the application of artificial intelligence is not far, and it will create a new generation and trend.
BBTF will keep staying in the forefront by the development and usage of high-end technology to assist the global world. We will play in a role with the concept of ‘Great Health’. Using data to analyze the market trend, assisting scientific research, producing development and in order to grasp the future trend. BBT group will definitely develop rapidly with innovative business thinking.